CytomX Therapeutics, Inc.
CTMX· Nasdaq
CTMXCytomX Therapeutics, Inc.
Quarterly figures for CytomX Therapeutics, Inc., with source filings when available.
50 quarters. Mar 31, 2014 to Jun 30, 2026. USD.
CytomX Therapeutics, Inc. has filed its 10-Q within 37 to 42 days of period end across its last 8 quarters. The 10-K runs 55 to 86 days.
CytomX Therapeutics, Inc. · CIK 1501989 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 · after-hours | Aug 6, 2026 | 37 d | 10-Q | $1.42M | −92.4% | -$0.09 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 7, 2026 · after-hours |
| May 7, 2026 |
| 37 d |
| 10-Q |
| $10.26M |
| −79.9% |
| -$0.10 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 16, 2026 · pre-market | Mar 16, 2026 | 75 d | 10-K | $663.00K | −98.3% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 6, 2025 · after-hours | Nov 6, 2025 | 37 d | 10-Q | $5.96M | −82.2% | -$0.09 | |
| Q2 2025 | Jun 30, 2025 | Aug 7, 2025 · after-hours | Aug 7, 2025 | 38 d | 10-Q | $18.66M | −25.7% | $0.00 | |
| Q1 2025 | Mar 31, 2025 | May 12, 2025 · pre-market | May 12, 2025 | 42 d | 10-Q | $50.92M | +22.8% | $0.27 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 6, 2025 · after-hours | Mar 6, 2025 | 65 d | 10-K | $38.09M | +43.2% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 7, 2024 · after-hours | Nov 7, 2024 | 38 d | 10-Q | $33.43M | +26.7% | $0.07 | |
| Q2 2024 | Jun 30, 2024 | Aug 8, 2024 · after-hours | Aug 8, 2024 | 39 d | 10-Q | $25.12M | +1.6% | -$0.08 | |
| Q1 2024 | Mar 31, 2024 | May 8, 2024 · after-hours | May 8, 2024 | 38 d | 10-Q | $41.46M | +76.4% | $0.17 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 11, 2024 · after-hours | Mar 11, 2024 | 71 d | 10-K | $26.61M | +32.2% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 7, 2023 · after-hours | Nov 7, 2023 | 38 d | 10-Q | $26.38M | +136.7% | $0.04 | |
| Q2 2023 | Jun 30, 2023 | Aug 8, 2023 · after-hours | Aug 8, 2023 | 39 d | 10-Q | $24.72M | +92.4% | -$0.02 | |
| Q1 2023 | Mar 31, 2023 | May 9, 2023 · after-hours | May 9, 2023 | 39 d | 10-Q | $23.50M | +159.9% | -$0.05 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 27, 2023 · after-hours | Mar 27, 2023 | 86 d | 10-K | $20.12M | +80.8% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 8, 2022 · after-hours | Nov 8, 2022 | 39 d | 10-Q | $11.15M | +21.3% | -$0.44 | |
| Q2 2022 | Jun 30, 2022 | Aug 4, 2022 · after-hours | Aug 4, 2022 | 35 d | 10-Q | $12.85M | +46.1% | -$0.45 | |
| Q1 2022 | Mar 31, 2022 | May 5, 2022 · after-hours | May 5, 2022 | 35 d | 10-Q | $9.04M | +10.3% | -$0.49 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021 | Dec 31, 2021 | Mar 1, 2022 · after-hours | Mar 1, 2022 | 60 d | 10-K | $11.13M | +57.3% | -$0.53 | |
| Q3 2021 | Sep 30, 2021 | — | Nov 4, 2021 | 35 d | 10-Q | $9.19M | +23.1% | -$0.48 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 5, 2021 | 36 d | 10-Q | $8.80M | +25.9% | -$0.41 | |
| Q1 2021 | Mar 31, 2021 | — | May 6, 2021 | 36 d | 10-Q | $8.20M | −82.5% | -$0.38 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020 | Dec 31, 2020 | — | Feb 24, 2021 | 55 d | 10-K | $7.08M | −14.5% | -$0.51 | |
| Q3 2020 | Sep 30, 2020 | — | Nov 5, 2020 | 36 d | 10-Q | $7.47M | −30.3% | -$0.54 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 6, 2020 | 37 d | 10-Q | $6.99M | −22.5% | -$0.55 | |
| Q1 2020 | Mar 31, 2020 | — | May 7, 2020 | 37 d | 10-Q | $46.90M | +59.0% | $0.20 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | — | Feb 27, 2020 | 58 d | 10-K | $8.28M | −27.8% | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 7, 2019 | 38 d | 10-Q | $10.71M | −14.4% | — | |
| Q2 2019 | Jun 30, 2019 | — | Aug 7, 2019 | 38 d | 10-Q | $9.01M | −57.8% | — | |
| Q1 2019 | Mar 31, 2019 | — | May 9, 2019 | 39 d | 10-Q | $29.49M | +107.9% | -$0.31 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | — | Feb 27, 2019 | 58 d | 10-K | $11.47M | −57.6% | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 6, 2018 | 37 d | 10-Q | $12.51M | −48.2% | — | |
| Q2 2018 | Jun 30, 2018 | — | Aug 8, 2018 | 39 d | 10-Q | $21.34M | +143.8% | — | |
| Q1 2018 | Mar 31, 2018 | — | May 9, 2018 | 39 d | 10-Q | $14.18M | +21.7% | — | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 31, 2017 | — | Mar 7, 2018 | 66 d | 10-K | $27.07M | +331.7% | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 7, 2017 | 38 d | 10-Q | $24.14M | +599.0% | — | |
| Q2 2017 | Jun 30, 2017 | — | Aug 7, 2017 | 38 d | 10-Q | $8.75M | +182.9% | -$0.69 | |
| Q1 2017 | Mar 31, 2017 | — | May 5, 2017 | 35 d | 10-Q | $11.65M | +424.2% | -$0.23 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | — | Mar 2, 2017 | 61 d | 10-K | $6.27M | +215.5% | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 3, 2016 | 34 d | 10-Q | $3.45M | +78.1% | -$0.40 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 3, 2016 | 34 d | 10-Q | $3.09M | +51.4% | -$0.39 | |
| Q1 2016 | Mar 31, 2016 | — | May 6, 2016 | 36 d | 10-Q | $2.22M | +27.6% | -$0.44 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Dec 31, 2015 | — | Mar 7, 2016 | 67 d | 10-K | $1.99M | +6.8% | — | |
| Q3 2015 | Sep 30, 2015 | — | Nov 23, 2015 | 54 d | 10-Q | $1.94M | +1.3% | -$14.26 | |
| Q2 2015 | Jun 30, 2015 | — | — | — | — | $2.04M | +206.8% | -$7.56 | |
| Q1 2015 | Mar 31, 2015 | — | — | — | — | $1.74M | +174.3% | -$7.56 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014 | Dec 31, 2014 | — | — | — | — | $1.86M | — | — | |
| Q3 2014 | Sep 30, 2014 | — | — | — | — | $1.92M | — | -$4.86 | |
| Q2 2014 | Jun 30, 2014 | — | — | — | — | $666.00K | — | — | |
| Q1 2014 | Mar 31, 2014 | — | — | — | — | $635.00K | — | — | |
